ZYLOXTB (02190.HK) Repurchases 100,000 H Shares for HK$2.18 Million

Bulletin Express03-18

Zylox-Tonbridge Medical Technology Co., Ltd. (stock code: 02190.HK, “ZYLOXTB”) filed a Next Day Disclosure Return on 18 March 2026, detailing a share buyback executed on the same date.

The company repurchased 100,000 H shares on the Hong Kong Stock Exchange at prices ranging from HK$21.26 to HK$22.18, representing a volume-weighted average of HK$21.82 per share. Total consideration paid amounted to HK$2.18 million. All repurchased shares have been retained as treasury shares; none were cancelled.

Following the transaction, the number of issued shares (excluding treasury shares) fell 0.03 % from 329.50 million to 329.40 million, while treasury shares increased from 6.85 million to 6.95 million. Total issued shares remained unchanged at 336.35 million.

The buyback was carried out under the general mandate granted on 30 May 2025, which authorises repurchases of up to 31.96 million shares. Cumulative repurchases under this mandate now stand at 4.13 million shares, equating to 1.26 % of the company’s issued share capital at the mandate date.

Under Hong Kong listing rules, ZYLOXTB is subject to a moratorium on issuing new shares or disposing of treasury shares until 17 April 2026. The board confirmed that the repurchase complied with all applicable regulations and internal authorisations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1127067831?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-18 19:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1127067831","market":"us","top_or_hot":-1,"title":"ZYLOXTB (02190.HK) Repurchases 100,000 H Shares for HK$2.18 Million","media":"Bulletin Express","content":"<p>Zylox-Tonbridge Medical Technology Co., Ltd. (stock code: 02190.HK, “ZYLOXTB”) filed a Next Day Disclosure Return on 18 March 2026, detailing a share buyback executed on the same date.</p>\n<p>The company repurchased 100,000 H shares on the Hong Kong Stock Exchange at prices ranging from HK$21.26 to HK$22.18, representing a volume-weighted average of HK$21.82 per share. Total consideration paid amounted to HK$2.18 million. All repurchased shares have been retained as treasury shares; none were cancelled.</p>\n<p>Following the transaction, the number of issued shares (excluding treasury shares) fell 0.03 % from 329.50 million to 329.40 million, while treasury shares increased from 6.85 million to 6.95 million. Total issued shares remained unchanged at 336.35 million.</p>\n<p>The buyback was carried out under the general mandate granted on 30 May 2025, which authorises repurchases of up to 31.96 million shares. Cumulative repurchases under this mandate now stand at 4.13 million shares, equating to 1.26 % of the company’s issued share capital at the mandate date.</p>\n<p>Under Hong Kong listing rules, ZYLOXTB is subject to a moratorium on issuing new shares or disposing of treasury shares until 17 April 2026. The board confirmed that the repurchase complied with all applicable regulations and internal authorisations.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ZYLOXTB (02190.HK) Repurchases 100,000 H Shares for HK$2.18 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZYLOXTB (02190.HK) Repurchases 100,000 H Shares for HK$2.18 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-18 19:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zylox-Tonbridge Medical Technology Co., Ltd. (stock code: 02190.HK, “ZYLOXTB”) filed a Next Day Disclosure Return on 18 March 2026, detailing a share buyback executed on the same date.</p>\n<p>The company repurchased 100,000 H shares on the Hong Kong Stock Exchange at prices ranging from HK$21.26 to HK$22.18, representing a volume-weighted average of HK$21.82 per share. Total consideration paid amounted to HK$2.18 million. All repurchased shares have been retained as treasury shares; none were cancelled.</p>\n<p>Following the transaction, the number of issued shares (excluding treasury shares) fell 0.03 % from 329.50 million to 329.40 million, while treasury shares increased from 6.85 million to 6.95 million. Total issued shares remained unchanged at 336.35 million.</p>\n<p>The buyback was carried out under the general mandate granted on 30 May 2025, which authorises repurchases of up to 31.96 million shares. Cumulative repurchases under this mandate now stand at 4.13 million shares, equating to 1.26 % of the company’s issued share capital at the mandate date.</p>\n<p>Under Hong Kong listing rules, ZYLOXTB is subject to a moratorium on issuing new shares or disposing of treasury shares until 17 April 2026. The board confirmed that the repurchase complied with all applicable regulations and internal authorisations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02190","symbol_name":"归创通桥","start_time":0,"source_url":"","article_id":"1127067831","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1127067831","pubTimestamp":1773832929,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zylox-Tonbridge Medical Technology Co., Ltd. (stock code: 02190.HK, “ZYLOXTB”) filed a Next Day Disclosure Return on 18 March 2026, detailing a share buyback executed on the same date. The company...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02190":"归创通桥"},"translate_title":"ZYLOXTB(02190.HK)218万港元回购10万股H股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02190":1},"content_text":"Zylox-Tonbridge Medical Technology Co., Ltd. (stock code: 02190.HK, “ZYLOXTB”) filed a Next Day Disclosure Return on 18 March 2026, detailing a share buyback executed on the same date.\nThe company repurchased 100,000 H shares on the Hong Kong Stock Exchange at prices ranging from HK$21.26 to HK$22.18, representing a volume-weighted average of HK$21.82 per share. Total consideration paid amounted to HK$2.18 million. All repurchased shares have been retained as treasury shares; none were cancelled.\nFollowing the transaction, the number of issued shares (excluding treasury shares) fell 0.03 % from 329.50 million to 329.40 million, while treasury shares increased from 6.85 million to 6.95 million. Total issued shares remained unchanged at 336.35 million.\nThe buyback was carried out under the general mandate granted on 30 May 2025, which authorises repurchases of up to 31.96 million shares. Cumulative repurchases under this mandate now stand at 4.13 million shares, equating to 1.26 % of the company’s issued share capital at the mandate date.\nUnder Hong Kong listing rules, ZYLOXTB is subject to a moratorium on issuing new shares or disposing of treasury shares until 17 April 2026. The board confirmed that the repurchase complied with all applicable regulations and internal authorisations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1127067831","isCrawlerRequest":true}